Zobrazeno 1 - 10
of 165
pro vyhledávání: '"A. N. Kazakova"'
Autor:
Zh. V. Permikin, A. M. Popov, T. Yu. Verzhbitskaya, Т. О. Riger, O. R. Arakaev, A. A. Vlasova, Yu. V. Olshanskaya, A. N. Kazakova, S. V. Tsvirenko, L. I. Saveliev, G. A. Tsaur, L. G. Fechina
Publikováno v:
Онкогематология, Vol 13, Iss 4, Pp 93-103 (2019)
The objective of the study was searching for surface antigen expression that could predict presence of translocation t(12;21)(p13;q22)/ETV6RUNX1 in pediatric B-cell precursor acute lymphoblastic leukemia patients.Results . ETV6-RUNX1 fusion gene tran
Externí odkaz:
https://doaj.org/article/7df96cae510e4d25b9669daca3c185d4
Autor:
I. A. Demina, O. I. Illarionova, T. Yu. Verzhbitskaya, G. A. Tsaur, E. B. Rusanova, M. V. Gorchakova, E. E. Zueva, M. B. Belogurova, G. I. Uleiskaya, L. A. Shchekina, A. N. Kazakova, E. A. Zerkalenkova, Yu. V. Olshanskaya, Yu. G. Abugova, l. G. Fechina, N. V. Miakova, E. V. Samochatova, A. A. Maschan, A. M. Popov
Publikováno v:
Онкогематология, Vol 13, Iss 3, Pp 76-82 (2018)
Introduction. The main features of bone marrow blasts cells in Burkitt lymphoma/leukemia (BL) are L3 morphology, mature immunophenotype of blasts with surface IgM expression, and presence of typical MYC gene rearrangements.The aim of the study was to
Externí odkaz:
https://doaj.org/article/4130c991b9de46b287bc2bc5e336bf65
Autor:
I. A. Demina, Т. Yu. Verzhbitskaya, S. A. Kashpor, L. V. Baidun, T. V. Koniuhova, S. A. Plyasunova, G. А. Tsaur, E. B. Rusanova, M. V. Gorchakova, E. E. Zueva, A. N. Kazakova, E. A. Zerkalenkova, Yu. V. Olshanskaya, Yu. G. Abugova, L. G. Fechina, N. V. Miakova, E. V. Samochatova, А. А. Maschan, А. M. Popov
Publikováno v:
Онкогематология, Vol 12, Iss 4, Pp 34-40 (2018)
Introduction. Surface immunoglobulin expression is a main immunophenotypic criteria of mature subtype of B-lineage acute lymphoblastic leukemia. Although the majority of such cases represents Burkitt leukemia/lymphoma, it was shown for several times
Externí odkaz:
https://doaj.org/article/f627e049edb64d5ea4bf26c1dff209da
Autor:
E. A. Zerkalenkova, O. I. Illarionova, A. N. Kazakova, N. I. Ponomareva, L. V. Baydun, E. Yu. Osipova, M. E. Dubrovina, A. M. Popov, T. V. Konyukhova, S. A. Plyasunova, N. V. Myakova, A. A. Maschan, Yu. V. Olshanskaya
Publikováno v:
Онкогематология, Vol 11, Iss 2, Pp 21-29 (2016)
Lineage switch is a rare phenomenon in which a transition from lymphoid to myeloid was observed in relapse of acute leukemia, or vice versa. This paper presents the four clinical case reports of acute lymphoblastic leukemia with MLL gene rearrangemen
Externí odkaz:
https://doaj.org/article/1cb2879f77984511ab1e04d6a383de28
Autor:
E. A. Matveeva, A. N. Kazakova, I. I. Kalinina, M. E. Dubrovina, L. V. Baydun, M. A. Maschan, Yu. V. Olshanskaya, A. A. Maschan
Publikováno v:
Онкогематология, Vol 7, Iss 2, Pp 51-56 (2014)
Acute megakaryocytic leukemia (AML M7) – a rare disease characterized by poor treatment response, except for t(1;22) variant in infants. Cytogenetic abnormalities in AML M7 are highly heterogeneous. We collected samples from children with AML M7 to
Externí odkaz:
https://doaj.org/article/3500caa759c74cc487b3235952011626
Autor:
Natalya A. Borozdina, Ekaterina N. Kazakova, Irina N. Gladkikh, Elena V. Leychenko, Igor A. Dyachenko
Publikováno v:
Research Results in Pharmacology, Vol 10, Iss 2, Pp 65-72 (2024)
Introduction: α-amylase inhibitors are an important class of second-line antihyperglycemic drugs. They slow down the breakdown and absorption of carbohydrates, reducing peak glucose concentration with meals. Recent reports have also shown other bene
Externí odkaz:
https://doaj.org/article/3084ee644bbd4961a9c6bbc4f63d739b
Autor:
Anastasia N. Kazakova, Maria M. Lukina, Ksenia S. Anufrieva, Irina V. Bekbaeva, Olga M. Ivanova, Polina V. Shnaider, Andrey Slonov, Georgij P. Arapidi, Victoria O. Shender
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
Introduction: Among the various stromal cell types within the tumor microenvironment, cancer-associated fibroblasts (CAFs) emerge as the predominant constituent, exhibiting a diverse array of oncogenic functions not intrinsic to normal fibroblasts. T
Externí odkaz:
https://doaj.org/article/84b940d6fecf41b2a078e54d02e89873
Autor:
Margarita E. Bogomiakova, Elizaveta K. Sekretova, Ksenia S. Anufrieva, Polina O. Khabarova, Anastasia N. Kazakova, Pavel A. Bobrovsky, Tatiana V. Grigoryeva, Artem V. Eremeev, Olga S. Lebedeva, Alexandra N. Bogomazova, Maria A. Lagarkova
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-18 (2023)
Abstract Background Dozens of transplants generated from pluripotent stem cells are currently in clinical trials. The creation of patient-specific iPSCs makes personalized therapy possible due to their main advantage of immunotolerance. However, some
Externí odkaz:
https://doaj.org/article/ef471964d50e4eee9e56dfe6e3ec3f68
Autor:
Olga M. Ivanova, Ksenia S. Anufrieva, Anastasia N. Kazakova, Irina K. Malyants, Polina V. Shnaider, Maria M. Lukina, Victoria O. Shender
Publikováno v:
Cell Death and Disease, Vol 14, Iss 2, Pp 1-17 (2023)
Abstract Dysregulation of pre-mRNA splicing is a common hallmark of cancer cells and it is associated with altered expression, localization, and mutations of the components of the splicing machinery. In the last few years, it has been elucidated that
Externí odkaz:
https://doaj.org/article/e14422d3f8f04e8e8af54fd9d26ed899
Autor:
T. V. Shamanskaya, S. R. Varfolomeeva, D. Yu. Kachanov, R. A. Moiseenko, M. V. Teleshova, D. M. Konovalov, V. Yu. Roshchin, A. N. Kazakova, L. V. Zemtsova, A. E. Drui, M. Ya. Yadgarov, G. V. Tereshchenko, A. P. Shcherbakov, Yu. N. Likar, M. N. Sukhov, N. S. Grachev, D. G. Akhaladze, M. A. Maschan, A. V. Nechesnyuk, A. V. Pshonkin, E. E. Kurnikova, E. V. Skorobogatova, L. A. Khachatryan, D. K. Fomin, A. A. Maschan, A. G. Rumyantsev, G. A. Novichkova
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:65-91
Treatment of patients with high-risk neuroblastoma (NB) is a complex challenge, and it is based on response to certain elements of therapy. The development and introduction of new treatment approaches, such as GD2-targeted immunotherapy (IT), leads t